eBook Encyclopedia of Cancer, 3rd Edition

  • Editor: Manfred Schwab
  • Published By:
  • ISBN-10: 3642164838
  • ISBN-13: 9783642164835
  • DDC: 616.99
  • Grade Level Range: College Freshman - College Senior
  • 15429 Pages | eBook
  • Original Copyright 2012 | Published/Released September 2013
  • This publication's content originally published in print form: 2012
  • Price:  Sign in for price

About

Overview

The merging of different basic and clinical science disciplines towards the common goal of fighting against cancer has long ago called for the establishment of a comprehensive reference source both as a tool to close the language gap between clinical and basic science investigators and as a platform of information for students and informed laymen alike. The Encyclopedia of Cancer provides rapid access to focused information on all topics of cancer research for clinicians, research scientists and advanced students. Given the overwhelming success of the Second Edition, which appeared in 2009, and fast recent development in the different fields of cancer research, it has been decided to publish a third fully revised and expanded edition, following the principal concept of the first edition that has proven so successful. Recent developments are seeing a dynamic progress in basic and clinical cancer science, with translational research increasingly becoming a new paradigm in cancer research. In particular, new approaches to both Personalized Cancer Medicine and Targeted Therapies have made promising progress. While the Second Edition featured scholarly contributions from approximately 1.000 scientists/clinicians in four Volumes, the Third Edition includes 1.300 contributors in 7 Volumes with an A-Z format of approx. 7000 entries. It provides definitions of common acronyms and short definitions of related terms and processes in the form of keyword entries. In addition, there are detailed essays, which provide comprehensive information on syndromes, genes and molecules, and processes and methods. Each essay is well-structured, with extensive cross-referencing between all entries.

Features and Benefits

  • Easy to use: A-Z format provides quick access to relevant info in the form of standardized entries.
  • Comprehensive: Over 7,000 entries, both keywords & detailed essays.
  • Includes info of all biomolecules, types of cancer, pathways and therapies of great importance in the field.

Contributors

Contributors

  • Manfred Schwab

Table of Contents

Front Cover.
Half Title Page.
Title Page.
Other Frontmatter.
Copyright Page.
Preface to the Third Edition.
Preface to the Second Edition.
Preface to the First Edition.
Editor-in-Chief.
Contributors.
1: AAA+.
2: AAMP.
3: AAV.
4: ABC (ATP-Binding Cassette) Superfamily.
5: ABC Drug-Transporters.
6: ABC Transporter Proteins.
7: ABC-Transporters.
8: Aberrant Crypt Foci.
9: ABL.
10: Ablation.
11: ABLES.
12: Abraxas.
13: ABT-888.
14: ABVD.
15: Accelerated Phase.
16: ACD.
17: Acetaldehyde.
18: Acetaldehydehydrogenase.
19: Acetylation.
20: Acetylsalicylic Acid.
21: Acetyltransferase.
22: ACF.
23: Acharan Sulfate.
24: Achneiform Rash.
25: Acid Rain.
26: Acidosis.
27: Acinar Cells.
28: Aclarubicin.
29: Acquired Immunodeficiency Syndrome.
30: Acquired Mutation.
31: Acromegaly.
32: ACTH.
33: Actin.
34: Actin Cytoskeleton.
35: Actin Filament Severing.
36: Actinic Keratosis.
37: Actinomycin D.
38: Activated Natural Killer Cells.
39: Activation Loop.
40: Active Immunity.
41: Active Specific Immunization.
42: Acute Lung Injury.
43: Acute Lymphoblastic Leukemia.
44: Acute Megakaryoblastic Leukemia.
45: Acute Myeloid Leukemia.
46: Acute Promyelocytic Leukemia.
47: Acute Respiratory Distress Syndrome.
48: Acyclovir.
49: AD.
50: ADAM.
51: ADAM Molecules.
52: ADAM10.
53: ADAM17.
54: Adaptive Immunity.
55: Adaptive Response.
56: Adaptor Proteins.
57: ADAR.
58: ADCC.
59: Additive Effects.
60: Adduct.
61: Adducts to DNA.
62: Adenine Nucleotides.
63: Adenocarcinoid.
64: Adenocarcinoma.
65: Adenoma.
66: Adenomatous Polyposis Coli.
67: Adenomucinosis.
68: Adenopathy.
69: Adenosine and Tumor Microenvironment.
70: Adenosine Deaminase.
71: Adenovirus.
72: Adenylyl Cyclase.
73: Adherens Junctions.
74: Adhesion.
75: Adhesion Molecules.
76: Adipocytes.
77: Adipokine.
78: Adiponectin.
79: Adipose Tumors.
80: Adjuvant.
81: Adjuvant Chemoendocrine Therapy.
82: Adjuvant Effect.
83: Adjuvant Therapy.
84: ADMET.
85: ADMET Screen.
86: Admixture Population.
87: Adnexal Mass.
88: Adoptive Immunotherapy.
89: Adrenal Cortex.
90: Adrencorticotropic Hormone.
91: Adrenocortical Cancer.
92: Adrenocortical Tumors.
93: Adrenomedullin.
94: Adriamycin.
95: Adult Stem Cells.
96: Adult T-cell Leukemia.
97: Adult Tissue Stem Cells.
98: Adult-Onset Diabetes.
99: Advanced Breast Cancer.
100: AEL.
101: Aesthetic and Reconstructive Surgery of the Breast.
102: Afaxin.
103: Affinity-Matured IgG Response.
104: Afinitor.
105: Aflatoxin B1.
106: Aflatoxins.
107: Aflibercept.
108: AFP-L3.
109: Agammaglobulinemia.
110: AGEs.
111: Aggressive Fibromatosis in Children.
112: Aging.
113: Aging-Associated Inflammation.
114: Agonist.
115: AHNP.
116: AHR.
117: AI.
118: AIF.
119: AIPC.
120: AIs.
121: AIT.
122: AJCC.
123: Ajuba.
124: AKT.
125: Akt Signal Transduction Pathway.
126: ALA.
127: ALAD.
128: Alcohol Consumption.
129: Alcohol Dehydrogenase.
130: Alcoholic Beverages Cancer Epidemiology.
131: Alcoholic Pancreatitis.
132: Alcohol-Mediated Cancer.
133: ALD.
134: Aldehyde Dehydrogenases.
135: Aldehydes.
136: Aldo-Keto Reductase.
137: Aldose Reductase.
138: Alemtuzumab.
139: ALK.
140: ALK Protein.
141: Alkeran.
142: Alkyl.
143: Alkylating Agents.
144: All.
145: Allele.
146: Allele Imbalance.
147: Allelic Loss.
148: Allergen.
149: Allergen-Specific Immunotherapy.
150: Allergic Disease.
151: Allergy.
152: Allodynia.
153: Allogeneic.
154: Allogeneic Cell Therapy.
155: Allograft.
156: Allograft Rejection.
157: Allopurinol.
158: Allylic Structures.
159: Alpha2-Agonist.
160: Alpha-Actinin.
161: Alpha-Fetoprotein.
162: Alpha-Fetoprotein Diagnostics.
163: Alpha-Particles.
164: 5-Alpha Reductase.
165: Alpha-SMA.
166: Alternative Lengthening of Telomeres.
167: Alternative RNA Splicing.
168: Alu Elements.
169: ALVAC-CEA.
170: Alveolar Rhabdomyosarcoma.
171: Alveolar Soft Part Sarcoma.
172: AMAP1.
173: AME Transcription Factor.
174: Amenorrhea.
175: Ames Assay.
176: Amidation.
177: Amifostine.
178: Amine Oxidases.
179: Amino Terminal End.
180: Aminoflavone.
181: 5-Aminolevulinic Acid.
182: δ-Aminolevulinic Acid.
183: AML.
184: AML-1/ETO/CBFβ/TEL in Chromosomal Translocations.
185: Amosite.
186: Amphipathic.
187: Amphiregulin.
188: Amphitropic Proteins.
189: AMPK.
190: Amplification.
1: C75.
2: Ca2+ ATPase.
3: Ca2+-Release Channels.
4: CA125.
5: CA15-3.
6: CA19-9.
7: CA27-29.
8: C-Abl.
9: Cachexia.
10: Caco-2.
11: Cadherin 1.
12: Cadherins.
13: Cafe-Au-Lait Spots.
14: Cajal Bodies.
15: Cal.
16: Calcineurin.
17: Calcitonin.
18: Calcitriol.
19: Calcium-Binding Proteins.
20: Calla.
21: Call-Exner Bodies.
22: Calnexin.
23: Calpain.
24: Calpastatin.
25: Calreticulin.
26: Calretinin.
27: CAM.
28: CAMP.
29: CAMP Response Element Binding Protein.
30: Campath-1H.
31: Camptothecin.
32: CAMTA1.
33: Canale-Smith Syndrome.
34: Canals of Hering.
35: Cancer.
36: Cancer and Cadmium.
37: Cancer Antigen.
38: Cancer Associated Antigen 27-29 (CA 27-29).
39: Cancer Cachexia Syndrome.
40: Cancer Causes and Control.
41: Cancer Epidemiology.
42: Cancer Epigenetics.
43: Cancer Genome Project.
44: Cancer Germline Antigens.
45: Cancer Networks.
46: Cancer Registry.
47: Cancer Stem Cells.
48: Cancer Stem-Like Cells.
49: Cancer Testis Antigens.
50: Cancer Vaccines.
51: Cancer-Associated Antigen 15-3.
52: Cancer-Associated Antigen 19-9.
53: Cancer-Associated Antigen 27-29.
54: Cancer-Prone Genetically Modified Mouse Models.
55: Cannabinoids.
56: Cap.
57: Cap-Binding Complex.
58: Cap-Dependent Translation.
59: Capecitabine.
60: CapG.
61: Capillary Hemangioblastoma.
62: Carboplatin.
63: Carboxylesterase.
64: Carboxypeptidase.
65: Carcinoembryonic Antigen.
66: Carcinogen.
67: Carcinogen Dosimetry.
68: Carcinogen Macromolecular Adducts.
69: Carcinogen Metabolism.
70: Carcinogenesis.
71: Carcinogenicity Studies.
72: Carcinoid.
73: Carcinoid Syndrome.
74: Carcinoid Tumors.
75: Carcinoma.
76: Carcinoma in Situ.
77: Carcinomatosis.
78: Carcinosarcoma.
79: CARD.
80: Cardiac Dysrhythmia.
81: Cardiac Myxoma.
82: Cardiac Tumors.
83: Cardio-Facial-Cutaneous (CFC) Syndrome.
84: Cardiomyopathy.
85: Cardiotoxicity.
86: Caretaker Genes.
87: Caries.
88: Carney Complex.
89: Carney-Stratakis Dyad.
90: Carotene 15,15′ -Oxygenase.
91: Carotenes.
92: β-Carotene.
93: Carotenoids.
94: Cas.
95: Case Control Association Study.
96: Case–Control Study.
97: CASP-8.
98: Caspase.
99: Caspase-3.
100: Caspase-8.
101: Caspase-9.
102: CASTing.
103: Castrate Level.
104: Castration-Resistant Prostate Cancer.
105: Catalytic Domain.
106: Catalytic Pocket.
107: Catastrophe Promoter.
108: Catechins.
109: Catechol Estrogen.
110: Catecholamines.
111: Catenate.
112: β-Catenin Stabilization.
113: Cathepsin-D.
114: Cathepsins.
115: Catheters.
116: Caveolae.
117: Caveolins.
118: Cavography.
119: C-Bandless Chromosome.
120: CBP/p300.
121: CBP/p300 Coactivators.
122: CBs.
123: CCAAT/Enhancer-Binding Protein α.
124: CCL20/MIP-3α.
125: CCL5/RANTES.
126: CCND1.
127: CCR4.
128: CCR6.
129: CCV.
130: CD Antibody Microarray.
131: CD Antigens.
132: CD117.
133: CD138.
134: CD14.
135: CD15.
136: CD1a.
137: CD20.
138: CD24.
139: CD26/DPPIV in Cancer Progression and Spread.
140: CD2AP.
141: CD3 Complex.
142: CD30.
143: CD33.
144: CD34.
145: CD38.
146: CD39.
147: CD4.
148: CD4+T-Cells.
149: CD40.
150: CD44.
151: CD45.
152: CD5 B Cells.
153: CD52.
154: CD56.
155: CD57.
156: CD66a.
157: CD73.
158: CD8.
159: CD8 T Cells.
160: CD8+ Cytotoxic T-Cells.
161: CD82.
162: CD95.
163: CD99.
164: CDC.
165: CDC20.
166: CDC25.
167: CDC37.
168: Cdc42.
169: CDC7.
170: CDH1.
171: CDK Inhibitors.
172: CDKN2A.
173: CEA Gene Family.
174: CEACAM1 Adhesion Molecule.
175: Ceacam1, Ceacam6, Ceacam7, Ceacam8.
176: CEA-Vaccine Virus.
177: C/EBP Homologous Protein.
178: C/EBPα.
179: CED-3.
180: CED-4.
181: Celastrol.
182: Celecoxib.
183: Cell Adhesion Molecules.
184: Cell Biology.
185: Cell Block.
186: Cell Cycle.
187: Cell Cycle Arrest.
188: Cell Cycle Checkpoint.
189: Cell Death.
190: Cell Differentiation.
191: Cell Division.
192: Cell Fate.
193: Cell Lines.
194: Cell Membrane.
195: Cell Migration.
196: Cell Polarity.
197: Cell Scattering.
198: Cell Signaling.
199: Cell-Adhesion Molecules.
200: Cell-Cycle Targets for Cancer Therapy.
1: Dactinomycin.
2: DAG.
3: Daltons.
4: D-Amino Acid.
5: DAMP.
6: Danazol.
7: DAP-10.
8: DAP-12.
9: Darier Sign.
10: Dasatinib.
11: Data Over-Fitting.
12: Daughter Cells.
13: Daunorubicin.
14: Daxx.
15: DBCCR1.
16: DCC.
17: DCIS.
18: DCX.
19: DDC3.
20: D-Dimer.
21: De Novo.
22: Deacetylation.
23: Death Domain.
24: Death Receptor Apoptosis Pathway.
25: Death Receptor-3.
26: Death Receptors.
27: Death-Effector-Domain.
28: Death-Inducing Signaling Complex.
29: Debulking.
30: Debulking Surgery.
31: Decatenation G2 Checkpoint.
32: Decay-Accelerating Factor.
33: Decoy Receptor.
34: Decoy Receptor 3.
35: DED.
36: Dedifferentiation.
37: Definitive Therapy.
38: Delayed Type Hypersensitivity Reaction.
39: Deleted in Colorectal Carcinoma.
40: Deleted in Malignant Brain Tumors 1.
41: Deleted in Pancreatic Carcinoma Locus 4.
42: Deletion.
43: Dendrimer.
44: Dendritic Cell–Based Tumor Vaccines.
45: Dendritic Cells.
46: Densitometric.
47: Dental Pulp.
48: Dental Pulp Neoplasms.
49: Dentin.
50: Denys–Drash Syndrome.
51: Deoxycytidine Kinase.
52: 2-Deoxy-D-Glucose.
53: Dermatofibrosarcoma Protuberans.
54: Dermoid Cyst.
55: DES Daughters.
56: DES Mothers.
57: DES Sons.
58: Descriptive Epidemiology.
59: Desert.
60: Des-Gamma-Carboxy Prothrombin.
61: Desmocollin.
62: Desmoglein.
63: Desmoglein-2.
64: Desmoid Tumor.
65: Desmoplakin.
66: Desmoplasia.
67: Desmoplastic.
68: Desmoplastic Medulloblastoma.
69: Desmoplastic Small Round Cell Tumor.
70: Desmosomal Cadherins.
71: Desmosomes.
72: Destruction Box.
73: Detox.
74: Detoxication.
75: Detoxification.
76: De-ubiquitinase.
77: De-ubiquitinating Enzymes.
78: Dexrazoxane.
79: DHT.
80: Diabetes.
81: Diabetes Type 2.
82: Diabody.
83: Diacylglycerol.
84: Diadzein.
85: Diagnostic Biomarkers.
86: Dicer.
87: Diet.
88: Dietary Micronutrient.
89: Dietary Supplement.
90: Diethylstilbestrol.
91: Differential Display.
92: Differentiation.
93: Diffuse Large B-Cell Lymphoma.
94: Diffuse Neuroendocrine System.
95: Diffusion.
96: Diffusional Flux.
97: Difluoromethylornithine.
98: Dihydrotestosterone.
99: 2-Dimensional Gel Replicon Mapping.
100: Dimer Formation.
101: Dimesna.
102: Dimethyl Benz(a)anthracene.
103: 7, 12 Dimethylbenz[a]anthracene.
104: Dimethylfumarate.
105: Dioxin.
106: Diphtheria Toxin.
107: Diploid.
108: Diplopia.
109: Direct Repeats.
110: Direct-Acting Carcinogen.
111: DISC.
112: Disposition.
113: Distamycin-A.
114: Distribution.
115: Disulfide.
116: Dithiol.
117: DKFZ.
118: DKK.
119: DLBCL.
120: DLC1.
121: DLT.
122: DM.
123: D-MAPP.
124: DMBA.
125: DMBA/TPA Mouse Skin Carcinogenesis Model.
126: DMBT1.
127: DNA.
128: DNA Adducts.
129: DNA Amplification.
130: DNA Aptamers.
131: DNA Damage.
132: DNA Damage Responses.
133: DNA Damage-Induced Apoptosis.
134: DNA Double Strand Breaks.
135: DNA Double-Strand Break Repair.
136: DNA Flexibility.
137: DNA Glycosylase.
138: DNA Methylation.
139: DNA Methyltransferases.
140: DNA Microarray.
141: DNA Mismatch Repair Mechanism.
142: DNA Photoproduct.
143: DNA Repair.
144: DNA Repair Capacity.
145: DNA Replication.
146: DNA Topoisomerases II.
147: DNA Vaccination.
148: DNA-Binding Domain.
149: DNA-Damage Tolerance.
150: DNA-Interstrand Crosslinks.
151: DNA-Methyl-Transferases.
152: DNA-PK.
153: DNMTs.
154: Docetaxel.
155: DOCK180/ELMO.
156: Docking Proteins.
157: Domain.
158: Domain Structure.
159: Dominant.
160: Dominant Negative.
161: Donor Lymphocyte Infusion.
162: Dopamine.
163: Doppler Ultrasound.
164: Dormancy.
165: Dose Fall-off.
166: Dose Homogeneity.
167: Dose Rate.
168: Dose-Dense.
169: Dose-Dense Chemotherapy.
170: Dose-Density.
171: Dose-Limiting Toxicity.
172: Dose-Response Curve.
173: Double Minute.
174: Double Strand Break.
175: Doublecortin.
176: Double-Strand Break DNA Repair.
177: Doublet Chemotherapy.
178: Down Syndrome.
179: Doxorubicin.
180: DR5.
181: DRE.
182: Drg-1.
183: Drosophila Melanogaster.
184: Drug Biodistribution.
185: Drug Carrier.
186: Drug Delivery Systems for Cancer Treatment.
187: Drug Design.
188: Drug Latency to Withdrawal.
189: Drug Resistance.
190: Drug Resistant.
191: Drug Tolerance.
192: DSS1.
193: DT40.
194: Ductal Carcinoma in Situ.
195: Ductal Carcinomas.
196: Duffy Antigen Receptor for Chemokines.
197: DUG.
198: Dukes Classification.
199: Dutasteride.
200: DUTP.
1: H Enzyme.
2: H&E Stain.
3: H-2.
4: γH2AX.
5: H60.
6: HA.
7: Hageman Factor.
8: Hair Cell Leukemia.
9: Hairy Cell Leukemia.
10: Half-life.
11: Halsted Radical Mastectomy.
12: Hamartin.
13: Hamartoma.
14: Hamartomatous.
15: Hamartomatous Polyposis.
16: Hamartomatous Polyposis Syndrome.
17: Hamartomatous Polyps.
18: HAND Gene Family.
19: Hand–Schǜller–Christian Disease.
20: Haploinsufficiency.
21: Haplotype.
22: Haptens.
23: Haptoglobin.
24: Haptotaxis.
25: Hardy–Weinberg Law.
26: HAS1.
27: HAS2.
28: HAS3.
29: Hashimoto Thyroiditis.
30: HAT.
31: HAUSP.
32: Hazard Ratio.
33: HB-EGF.
34: HC-11 Cells.
35: HCAEC.
36: HCC.
37: HD.
38: HDAC.
39: HDAC Inhibitors.
40: HDACs.
41: HDGC.
42: Hdmvec.
43: HE4.
44: Health Technology Appraisal.
45: Heat Shock Protein 70.
46: Hect.
47: Hedgehog.
48: Hedgehog Signaling.
49: HEK 293.
50: HeLa Cells.
51: Helicase.
52: Helicobacter Pylori.
53: Helix-Loop-Helix Domain.
54: Helix-Loop-Helix-Proteins.
55: Helper CD4 T-Cells.
56: Helper T Cells.
57: Hemangioblastoma.
58: Hemangioendothelioma.
59: Hemangioma.
60: Hemangiosarcoma.
61: Hematological Malignancies, Leukemias and Lymphomas.
62: Hematopoiesis.
63: Hematopoietic Niche.
64: Hematopoietic Progenitors.
65: Hematopoietic Stem Cell.
66: Hematopoietic Stem Cell Transplants.
67: Hematopoietic System.
68: Hematoporphyrin Derivative.
69: Hematoxylin and Eosin.
70: Hematuria.
71: Heme.
72: Heme-Oxygenase 1.
73: Hemichannel.
74: Hemihypertrophy.
75: Hemizygous.
76: Hemizygous Deletion.
77: Hemochromatosis.
78: Hemoglobin.
79: Hemoglobinopathy.
80: Hemosiderin.
81: Heparan Sulfate.
82: Heparan Sulfate Proteoglycans.
83: Heparanase.
84: Heparanase Inhibitors.
85: Heparin.
86: Hepatic Acinus.
87: Hepatic Epithelioid Hemangioendothelioma.
88: Hepatic Ethanol Metabolism.
89: Hepatic Excretion.
90: Hepatic Leukemia Factor.
91: Hepatic Stellate Cell.
92: Hepatitis.
93: Hepatitis B Virus.
94: Hepatitis B Virus x Antigen Associated Hepatocellular Carcinoma.
95: Hepatitis C Virus.
96: Hepatoblastoma.
97: Hepatocarcinoma.
98: Hepatocellular Carcinoma.
99: Hepatocellular Carcinoma – Etiology, Risk Factors and Prevention.
100: Hepatocyte.
101: Hepatocyte Activator Inhibitor-1.
102: Hepatocyte Growth Factor.
103: Hepatocyte Growth Factor.
104: Hepatomegaly.
105: Hepatosplenomegaly.
106: Hepsin.
107: HER2.
108: HER2/neu.
109: HER3.
110: Herceptin.
111: Hereditary Diffuse Gastric Cancer.
112: Hereditary Leiomyomatosis and Renal Cell Cancer.
113: Hereditary Nonpolyposis Colorectal Cancer.
114: Heregulin.
115: H-ERG.
116: Herniorrhaphy.
117: Herpes Simplex Virus.
118: Herpesvirus-Associated Ubiquitin-Specific Protease.
119: Herpesvirus-Associated Ubiquitin-Specific Protease De-ubiquitinase.
120: Heterochromatin.
121: Heterocromatic Regions.
122: Heterocyclic Amines.
123: Heterodimer.
124: Heterodimeric Complex.
125: Heteroduplex Analysis.
126: Heterokaryon.
127: Hetero-oligomers.
128: Heteroplasmy.
129: Heterotopia.
130: Heterotrimeric G-Proteins.
131: Heterozygosity.
132: Heterozygous.
133: Hexavalent Chromium.
134: HGF.
135: HGF Activator.
136: HHV-8.
137: HIF.
138: HIF-1.
139: HIF1a.
140: High Content Screen.
141: High Endothelial Venules.
142: High Mobility Group.
143: High Throughput Screens.
144: High-Dose Therapy with Stem-Cell Support.
145: High-Grade.
146: Hindgut.
147: HIP1r.
148: HIPK2.
149: Hirschsprung Disease.
150: Hirsutism.
151: Histiocytoid.
152: Histocompatibility.
153: Histocompatibility Antigens.
154: Histocompatibility Testing.
155: Histocultures.
156: Histogram.
157: Histology.
158: Histone.
159: Histone Acetylation.
160: Histone Acetyltransferases.
161: Histone Deacetylases.
162: Histone Deacetylation.
163: Histone Demethylases.
164: Histone H4.
165: Histone Methylation.
166: Histone Methyltransferase.
167: Histone Modification.
168: Histone Modifying Enzymes.
169: Histone Proteins.
170: Histones.
171: Histopathological.
172: HIV.
173: HLA.
174: HLA Class I.
175: HLH Domain.
176: HMEC-1.
177: HMGA1.
178: HMGA2.
179: HMG-CoA Reductase.
180: HMG-I/Y.
181: 4-HNE.
182: HNPCC.
183: HnRNP M.
184: HO-1.
185: Hoarseness.
186: Hodgkin and Reed/Sternberg Cell.
187: Hodgkin Disease.
188: Hodgkin Disease, Clinical Oncology.
189: Hodgkin Lymphoma.
190: Hoechst-33342 Dye.
191: Hollow Fiber Assay.
192: Homeobox.
193: Homeobox Genes.
194: Homeostasis.
195: Homeotic Genes.
196: Homer Wright Rosette.
197: Homing Peptides and Vascular Zip Codes.
198: Homo- or Heterodimers.
199: Homodimer.
200: Homogeneously Staining Region.
1: M Protein.
2: Machado-Joseph Disease.
3: Macrolide.
4: Macrometastasis.
5: Macrophages.
6: Macrophage-Stimulating Protein.
7: Macula Degeneration.
8: MAD.
9: Mad (Mxd).
10: Mage.
11: Mage-A4.
12: Magic Bullet.
13: Magnetic Resonance Imaging.
14: Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery.
15: Magnetic Resonance Tomography.
16: Maintenance Chemotherapy.
17: Major Histocompatibility Antigens.
18: Major Histocompatibility Complex.
19: Major Life Event.
20: Major Vault Protein.
21: Malignancy-Associated Changes.
22: Malignant Lymphoma: Hallmarks and Concepts.
23: Malignant Mixed Müllerian Tumor.
24: Malignant Peripheral Nerve Sheath Tumor.
25: Malignant Pleural Effusion.
26: Malignant Progression.
27: Malignant Tumor.
28: MALT Lymphoma.
29: Mammalian Target of Rapamycin.
30: MammaPrint.
31: MammaPrint Test.
32: Mammographic Breast Density and Cancer Risk.
33: Mammographic Density.
34: Mammography.
35: Mammosphere.
36: Mangosteen.
37: Mann–Whitney U-test.
38: Mantle Cell Lymphoma.
39: MAP Kinase.
40: MAP/ERK Kinase.
41: Mapatumumab.
42: MAPK.
43: Marginal Excision.
44: Marginal Zone B-Cell Lymphoma.
45: Marginal Zone Lymphoma.
46: Maspin.
47: Mass Spectrometry.
48: Mast Cells.
49: Mastectomy.
50: Mastitis.
51: Mastocytosis.
52: Matricellular Proteins.
53: Matrigel.
54: Matriptase.
55: Matrix Metalloproteinase 2.
56: Matrix Met-alloproteinase-7, -9.
57: Matrix Metalloproteinases.
58: Matrix-Assisted Laser Desorption/Ionization.
59: Matrix-Assisted Laser Desorption/Ionization-Time of Flight.
60: Mature B-cell Tumors.
61: Max.
62: Maximum Tolerable Dose.
63: Maximum Tolerated Dose.
64: MCA.
65: MCC.
66: McCune-Albright Syndrome.
67: Mcl Family.
68: Mcl-1.
69: MCM/P1 Proteins.
70: MCP-1.
71: MCPH1.
72: MCT-1 Oncogene.
73: MDC1.
74: MDM Genes.
75: MDM2.
76: MdmX.
77: MDR.
78: MDS.
79: Measles Virus.
80: Mechanical Properties.
81: Mechanical Stress.
82: Mechanosensor.
83: Mechanotransducer.
84: Mediastinoscopy.
85: Mediastinum.
86: Medroxyprogesterone Acetate.
87: Medullary Breast Carcinoma.
88: Medullary Thyroid Carcinoma.
89: Medulloblastoma.
90: Megestrol Acetate.
91: Melanin.
92: Melanocortin Receptor.
93: Melanocyte.
94: Melanocyte-Stimulating Hormone.
95: Melanocytic Tumors.
96: Melanoma.
97: Melanoma Antigens.
98: Melanoma Vaccines.
99: Melanoma-Associated Retinopathy.
100: Melanosomes.
101: Melanotic Medulloblastoma.
102: Melanotic Schwannoma.
103: Melatonin.
104: Melatonin Receptors.
105: Melphalan.
106: Melting Curve Analysis.
107: Membrane Fluidity.
108: Membrane Lipid Structure.
109: Membrane Permeability Transition.
110: Membrane Potential.
111: Membrane Transporters.
112: Membrane-Linked Docking Protein.
113: Membrane-Lipid Therapy.
114: Mendelian Distribution.
115: Meningeoma.
116: Meningioma.
117: Menopausal Symptoms After Breast Cancer Therapy.
118: Menopause.
119: Merlin.
120: Mesalazine.
121: Mesenchymal Stem Cells.
122: Mesenchymal Tumors.
123: Mesenchyme.
124: Mesna.
125: Mesoblastic Nephroma.
126: Mesoderm.
127: Mesothelial Cells.
128: Mesothelin.
129: Mesothelioma.
130: Messenger RNA.
131: Met.
132: MET, 11C-Methionine.
133: Meta-Analysis.
134: Metabolic Activation.
135: Metabolic Capability.
136: Metabolic Cooperation.
137: Metabolic Detoxification.
138: Metabolic Polymorphisms.
139: Metabolic Polymorphisms and Cancer Susceptibility.
140: Metabolic Trapping.
141: Metabolism.
142: Metabolite.
143: Metal Chelating.
144: Metalloenzymes.
145: Metalloproteases.
146: Metallothionein Enzymes.
147: Metallothioneins.
148: Metanephrine.
149: Metanephrogenic Blastema.
150: Metaphysis.
151: Metaplasia.
152: Metaplastic.
153: Metastasis.
154: Metastasis Signaling.
155: Metastasis Suppressor Gene.
156: Metastasis Suppressor KAI1/CD82.
157: Metastatic Breast Cancer Experimental Therapeutics.
158: Metastatic Colonization.
159: Metastatic Tumors.
160: Methemoglobinemia.
161: Methotrexate.
162: Methoxyestradiol.
163: Methyl Groups.
164: Methylation.
165: Methylation Status.
166: Methylation-Controlled J Protein.
167: Methylation-Specific PCR.
168: Methylator Phenotype.
169: Metronomic Chemotherapy.
170: Metrorrhagia.
171: Mevalonate.
172: Mga.
173: MGUS.
174: MHC.
175: MHC-Restricted Antigen Recognition.
176: MHF.
177: MIC Molecules.
178: MIC-1.
179: MICA, MICB.
180: Micelles.
181: Michaelis-Type Addition.
182: Microarray (cDNA) Technology.
183: Microautophagy.
184: Microbes.
185: Microbubbles.
186: Microcell.
187: Microcell Hybrid.
188: Microcell-Mediated Chromosome Transfer.
189: Microcirculation.
190: Microenvironment.
191: Microenvironmental Niche.
192: Microfold Cells.
193: Microglia.
194: Micrometastasis.
195: Micronucleus.
196: Micronucleus Assay.
197: Microprocessor Complex.
198: MicroRNA.
199: Microsatellite.
200: Microsatellite Instability.
1: P14ARF.
2: P16INK4A.
3: P19ARF.
4: p21.
5: P300.
6: P53.
7: P53 Family.
8: P53 Upregulated Modulator of Apoptosis.
9: P6 Protocol.
10: P73.
11: P8 Protein.
12: PAC.
13: Paclitaxel.
14: Paget Disease.
15: PAH.
16: PAK1.
17: PALB2.
18: Palliative.
19: Palliative Therapy.
20: Palmitoylated.
21: PAMPA.
22: Pancreas.
23: Pancreas Cancer.
24: Pancreas Cancer Basic and Clinical Parameters.
25: Pancreas Cancer Molecular Targets for Therapy.
26: Pancreas Cancer Stem Cells.
27: Pancreas Ductal Adenocarcinoma.
28: Pancreatic Cancer.
29: Pancreatic Islet Cells.
30: Pancreatitis.
31: Panitumumab.
32: Pannexins.
33: PAP Smear.
34: Papain.
35: Papanicolaou Test.
36: Papillary Carcinoma, Oncocytic Variant.
37: Papillary Thyroid Carcinoma.
38: Papilloma.
39: PAR.
40: Paracentesis.
41: Paracetamol.
42: Paracrine.
43: Paracrine Stimulation.
44: Paraesthesia.
45: Paraganglioma.
46: Paraganglioma Syndromes.
47: Paralogue.
48: Parametric.
49: Paraneoplastic Neuropathy.
50: Paraneoplastic Syndromes.
51: Parathyroid Glands.
52: Parathyroid Hormone-Related Protein.
53: Paresthesia.
54: Parity.
55: Parkinson Disease.
56: Parosteal Lipoma.
57: PARP.
58: PARP Inhibitors.
59: Particle-Induced Cancer.
60: Particulate Matter.
61: Parvovirus.
62: Passive Cell Death.
63: Passive Immunity.
64: Passive Targeting.
65: Patch-Clamp Technique.
66: Patched.
67: Pathogen-Associated Molecular Pattern.
68: Pathogenesis.
69: Pathology.
70: Patient Generated Subjective Global Assessment.
71: PAX.
72: PAX5.
73: Paxillin.
74: Pazopanib.
75: PBPC.
76: PBX.
77: PCA3.
78: PCNA.
79: PCP.
80: PCR.
81: PCT.
82: PDD.
83: PDGF.
84: PDGFR.
85: PDK1.
86: PDMP.
87: PDZ Domain.
88: PDZ Ligand.
89: PEA3.
90: PEComas.
91: PEG.
92: Pegylated Interferons.
93: Pegylation.
94: Pemetrexed.
95: Pemphigus.
96: Penetrance.
97: Pentakisphosphate.
98: PEP Syndrome.
99: Peptide Biomarkers.
100: Peptide Vaccines for Cancer.
101: Peptides.
102: Peptidomimetic.
103: Perforin.
104: Performance Status.
105: Pericardium.
106: Pericellular Matrix.
107: Pericyte.
108: Periodontium.
109: Periostin.
110: Peripheral Lymph Node Addressin Molecule.
111: Peripheral Lymphoid Organs.
112: Peripheral Membrane Proteins.
113: Peripheral Nervous System.
114: Peripheral Neurofibromatosis.
115: Peripheral Neuropathy.
116: Peritoneal Debulking Surgery.
117: Peritoneal Dissemination.
118: Peritoneal Mucinous Carcinoma.
119: Peritonectomy.
120: Peritoneovenous Shunt.
121: Peritoneum.
122: Peritoneum as the First Line of Defense.
123: PERK.
124: Perlman Syndrome.
125: Peroxisome.
126: Peroxisome Proliferator-Activated Receptor.
127: Personalized Cancer Medicine.
128: Personalized Medicine.
129: Pertussis Toxin.
130: Pertuzumab.
131: PEST Sequence.
132: PET.
133: PET/CT, Integrated Positron Emission Tomography/Computed Tomography.
134: Petechiae.
135: Peutz-Jeghers Syndrome.
136: Peyer Patches.
137: P-Glycroprotein.
138: PH Domain.
139: Phaeochromocytoma.
140: Phage.
141: Phage Display.
142: Phagemid.
143: Phagocyte.
144: Phagocytosis.
145: Phakomatoses.
146: Pharmacodynamics.
147: Pharmacogenetics.
148: Pharmacogenomics in Multidrug Resistance.
149: Pharmacogenotype.
150: Pharmacokinetic Profile.
151: Pharmacokinetics.
152: Pharmacokinetics and Pharmacodynamics in Drug Development.
153: Pharmacophore.
154: Phase 1 Enzymes.
155: Phase 2 Detoxification Enzymes.
156: Phase 2 Drug-Metabolizing Enzymes.
157: Phase 2 Proteins.
158: Phase I and II Clinical Trials.
159: Phase I Metabolism.
160: Phase II Biotransformation Enzymes.
161: Phase II Enzymes.
162: Phase II Metabolism.
163: Phenomics.
164: Phenotype.
165: Phenotype-Orientated Screens.
166: Phenylalanine Mustard.
167: Phenylaminopyrimidine.
168: Pheochromocytoma.
169: Philadelphia Chromosome.
170: Phlegm Dampness.
171: Phorbol 12-Myristate 13-Acetate.
172: Phorbol Ester.
173: Phosphatase.
174: Phosphatase and Tensin Homolog Deleted on Chromosome 10.
175: Phosphatidic Acid.
176: Phosphatidyl Inositol 3-Kinase.
177: Phosphatidylinositol Lipids.
178: Phosphatidylinositol-3,4,5-trisphosphate.
179: Phosphatidylserine.
180: Phosphodiesterase.
181: Phosphoinositide-Dependent Kinase-1.
182: Phosphoinositides.
183: Phospholipase.
184: Phospholipase A2.
185: Phospholipase A1.
186: Phospholipase C.
187: Phospholipase D.
188: Phospholipid Bilayer.
189: Phospholipids.
190: Phosphoprotein Enriched in Diabetes/Phosphoprotein Enriched in Astrocytes-15kDa.
191: Phosphorylation.
192: Photoactivation.
193: Photocarcinogenesis.
194: Photochemical Reaction Type-I.
195: Photochemical Reaction Type-II.
196: Photochemoprevention.
197: Photodamage.
198: Photodynamic Diagnostic.
199: Photodynamic Therapy.
200: Photofrin.
1: S-100 Protein.
2: S1P.
3: S-9.
4: SAAB.
5: SAGE.
6: SAHA.
7: Salivary Gland Malignancies.
8: Salmonella typhi and paratyphi.
9: Salpingo-Oophorectomy.
10: Salt Intake.
11: Salvage Chemotherapy.
12: Sanctuary Site.
13: Sandwich ELISA.
14: Sarcoid.
15: Sarcoma.
16: Satraplatin.
17: SBP.
18: SCA1.
19: Scaffold Proteins.
20: Scatter Factor.
21: Scavenge Free Radicals.
22: Scavenger Cells.
23: SCF.
24: ScFv.
25: Schiller-Duval Bodies.
26: Schistosomas Hematobium.
27: SCID.
28: Scid Mice.
29: SCID Mouse Model.
30: Scintigraphy.
31: SCLC.
32: Screening Toxicity.
33: SDF-1.
34: SEA Domain.
35: Seckel Syndrome.
36: Second Malignant Neoplasm.
37: Second Messenger.
38: Second Primary Malignancy.
39: Second Primary Tumors.
40: Secondary Amenorrhea.
41: Secondary Cancer Prevention.
42: Secondary Cancer Site.
43: Secondary Dissemination.
44: Secondary Hypogonadism.
45: Secondary Lymphedema.
46: Secondary Lymphoid Organs.
47: Secondary Structure.
48: Secondhand Tobacco Smoke.
49: Second-Tier/Third-Tier Lymph Node.
50: Secosteroid.
51: γ-Secretase.
52: Secreted Protein Acidic and Rich in Cysteine.
53: Secretor Enzyme.
54: Securin.
55: “Seed and Soil” Theory of Metastasis.
56: Seer.
57: Seldi-Tof Ms.
58: Selectins.
59: Selection Template.
60: Selective Estrogen Receptor Modulators.
61: Selenium.
62: Selenocysteine.
63: Selenoenzyme.
64: SELEX.
65: Self-Renewal.
66: Self-Sufficiency in Growth Signals.
67: Sella Turcica.
68: SEMA Domain.
69: Semaphorin.
70: SENCAR Mice.
71: Sendai Virus.
72: Senescence.
73: Senescence Accelerated.
74: Senescence and Immortalization.
75: Sensorineural.
76: Sentinel Lymph Node.
77: Sentinel Node.
78: Sentinel Node Biopsy.
79: Sentinel Vessels.
80: SEP.
81: Separin.
82: Sequence Identification.
83: Sequestered.
84: Ser/Thr-Phosphorylation.
85: SERCA.
86: SEREX.
87: Serine Protease.
88: Serine Protease Inhibitor.
89: Serine Proteases (Type II) Spanning the Plasma Membrane.
90: Serine/Threonine Kinase.
91: Serine-Threonine Kinase Receptor-Associated Protein.
92: Serm.
93: SERMs.
94: Serological Analysis of cDNA Expression Libraries.
95: Seropositive.
96: Serotonin.
97: Serotypes.
98: Serous.
99: Serpin.
100: Sertoli Cells.
101: Sertoli-Leydig Cell Tumor.
102: Serum.
103: Serum Biomarkers.
104: Serum-Ascites Albumin Concentration Gradient.
105: Seven Transmembrane Receptors.
106: Severe Combined Immunodeficiency Disease.
107: Severe Combined Immunodeficient Mice.
108: Sex Hormone.
109: Sex Hormone Dependent Cancers.
110: Sex-Cord Stromal Tumors.
111: Sezary Syndrome.
112: SFRP.
113: SH2 Domain.
114: SH2/SH3 Domains.
115: SH3 Domain.
116: SHANK.
117: Shark Cartilage.
118: Shc.
119: Shimada System.
120: SHP-1.
121: SHP-2.
122: SIADH.
123: Sialoglycoconjugates.
124: Sialyl Lewis-a/x Determinants.
125: Sialyltransferases.
126: Sicca Complex.
127: Signal Sequence.
128: Signal Transducers and Activators of Transcription in Oncogenesis.
129: Signal Transduction.
130: Signal Transduction Cross-Talk.
131: Signaling Cascades.
132: Signalosome.
133: Signal-Transducer Proteins.
134: Silencing Mediator of Retinoid and Thyroid Hormone Receptor.
135: Simian Virus 40.
136: Simulation.
137: SIN3A.
138: Single Cell Gel Electrophoresis Assay.
139: Single Cell Invasion.
140: Single Dose Toxicity Studies.
141: Single Nucleotide Polymorphism.
142: Single Stranded Conformation Analysis.
143: Single-Chain Fv Fragment.
144: Siomycin A.
145: SIOP.
146: Sipa-1.
147: Sipuleucel-T.
148: SiRNA.
149: SIRS.
150: Sirtuins.
151: Sister Chromatid Exchange.
152: Sister-Chromatids.
153: Site-Directed Mutagenesis.
154: Sivelestat.
155: Sjögren Syndrome.
156: Skeletal-Related Events.
157: Skeletrophin.
158: Ski.
159: Skin Cancer.
160: Skin Carcinogenesis.
161: Skin Prick Testing.
162: Skin-Sparing Mastectomy.
163: Skp2.
164: Skp-2.
165: SLD.
166: SLE.
167: SLex.
168: Slit.
169: Slug.
170: SM.
171: SMA.
172: SMAC/Diablo.
173: SMAD.
174: Smad Binding Element.
175: Smad Proteins in TGF-Beta Signaling.
176: Small Bowel Mesentery.
177: Small Cell Carcinomas.
178: Small Cell Lung Cancer.
179: Small Cell Lung Carcinoma.
180: Small GTPases.
181: Small Interfering RNA.
182: Small Molecule.
183: Small Molecule Drugs.
184: Small Molecule Screens.
185: Small-Molecule Inhibitors.
186: SMARCB1.
187: Smelting.
188: SMN.
189: Smoking.
190: Smoothened.
191: SMR.
192: SMRT Co-repressor.
193: SN-38.
194: SNAG.
195: Snail Transcription Factors.
196: SNCA.
197: SNCB.
198: SNCγ.
199: SnoRNA.
200: SNP.